These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1532503)

  • 1. Nasopharyngeal carcinoma: diagnosis, staging, and management.
    Neel HB
    Oncology (Williston Park); 1992 Feb; 6(2):87-95; discussion 99-102. PubMed ID: 1532503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of nasopharyngeal carcinoma.
    Jeyakumar A; Brickman TM; Jeyakumar A; Doerr T
    Ear Nose Throat J; 2006 Mar; 85(3):168-70, 172-3, 184. PubMed ID: 16615599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma. Clinical presentation, diagnosis, treatment, and prognosis.
    Neel HB
    Otolaryngol Clin North Am; 1985 Aug; 18(3):479-90. PubMed ID: 2995899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
    Neel HB
    J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal carcinoma: the role of magnetic resonance imaging in diagnosis, staging, treatment, and follow-up.
    Glastonbury CM
    Top Magn Reson Imaging; 2007 Aug; 18(4):225-35. PubMed ID: 17893588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma.
    Sam CK; Prasad U; Pathmanathan R
    Eur J Surg Oncol; 1989 Aug; 15(4):357-60. PubMed ID: 2547665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous carcinoma of the nasopharynx.
    Moloy PJ; Chung YT; Krivitsky PB; Kim RC
    West J Med; 1985 Jul; 143(1):66-9. PubMed ID: 2994305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Epstein-Barr virus-derived latent membrane protein-1 gene in various head and neck cancers: is it specific for nasopharyngeal carcinoma?
    Tsang NM; Chang KP; Lin SY; Hao SP; Tseng CK; Kuo TT; Tsai MH; Chung TC
    Laryngoscope; 2003 Jun; 113(6):1050-4. PubMed ID: 12782821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue polypeptide specific antigen (TPS) as a tumor marker in nasopharyngeal carcinoma.
    Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Anticancer Res; 2000; 20(6C):4661-3. PubMed ID: 11205197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization.
    Akao I; Sato Y; Mukai K; Uhara H; Furuya S; Hoshikawa T; Shimosato Y; Takeyama I
    Laryngoscope; 1991 Mar; 101(3):279-83. PubMed ID: 1847985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in nasopharyngeal carcinoma.
    Guigay J
    Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
    Guo ZM; Liu WW; He JH
    Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
    Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
    Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent allelic loss at the FRA3B site in endemic nasopharyngeal carcinoma: association with clinical features and Epstein-Barr virus infection.
    Deng YF; Zhou DN; Lu YD
    J Laryngol Otol; 2007 Nov; 121(11):1073-8. PubMed ID: 17359554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinomas in children and young adults: a new wave of a very rare tumor?
    Chow CW; Tabrizi SN; Tiedemann K; Waters KD
    J Pediatr Surg; 2007 Dec; 42(12):2035-9. PubMed ID: 18082703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasopharyngeal carcinoma.
    Wei WI; Sham JS
    Lancet; 2005 Jun 11-17; 365(9476):2041-54. PubMed ID: 15950718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curative surgery for recurrent nasopharyngeal carcinoma via the infratemporal fossa approach.
    Choi JY; Lee WS
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):213-6. PubMed ID: 15781760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
    Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
    Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
    Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
    Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary nasopharyngeal adenocarcinoma: a review.
    Xu T; Li ZM; Gu MF; Wei WH; Zhang GY; Wu QL; Su Y; Hu WH
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):123-31. PubMed ID: 22524571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.